Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.588 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 44.1 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Absorption: ECHA Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.8 section R8.4.2 (2012) states that in the absence of reliable data for both the starting route (oral) and the end route (inhalation), worst-case assumptions should be made. It was therefore assumed that limited absorption occurs by the oral route, leading to a low (conservative) internal NOAEL. To secure a conservative external NOAEL, maximum absorption should be assumed for the inhalation route (i.e. 100%) leading to a low external NOAEL. Thus, in the case of oral-to-inhalation extrapolation, it is proposed to include a default factor of 2 (i.e. the absorption percentage by the oral route is half that of the inhalation absorption)
Physiological Parameters: To convert the oral NOAEL into an inhalatory NOAEC, the following physiological parameters were applied.
Symbol Parameter Value/Reference Systemic NOAELlong-term Oral systemic NOAEL from OECD422 in rats 50 mg/kg bw/day sRVrat standard Respiratory Volume - rat, 8h exposure period 0.38 m3/kg/day sRVhuman standard Respiratory Volume - human, 8h exposure period 6.7 m3 wRV worker Respiratory Volume, 8h exposure period, light activity 10 m3 NB. For workers a correction was added for the difference between respiratory rates under standard conditions (sRVhuman) and under conditions of light activity (wRV).
Calculation: The corrected dose descriptor for inhalation is determined using the following equation:
Corrected Inhalatory NOAEClong-term = Systemic NOAELlong-term x [(1/sRVrat) x (ABSoral-rat/ABSinh-human) x (sRVhuman/wRV)].
Corrected Inhalatory NOAEClong-term = 50 mg/kg bw/day X [(1/0.38 m3/kg bw/day) X (1/2) X (6.7 m3/10m3)].
Corrected Inhalatory NOAEClong-term = 44.1 mg/m3
Therefore, the corrected dose descriptor for inhalation is 44.1 mg/m3 for workers.
- AF for dose response relationship:
- 1
- Justification:
- Table R.8-6 ECHA REACH Guidance 'dose-response': the dose-descriptor is a NOAEL therefore default value for systemic effects is 1.
- AF for differences in duration of exposure:
- 6
- Justification:
- Table R.8-6 ECHA REACH Guidance 'Exposure duration': default value for sub-acute to chronic is 6.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Table R.8-4 ECHA REACH Guidance: An assessment factor or interspecies differences is not to be used for inhalation exposure since the differences in the metabolic rate/bw have already been taken into account in the corrected dose descriptor starting point.
- AF for other interspecies differences:
- 2.5
- Justification:
- Table R.8-6 ECHA REACH Guidance 'interspecies': after correction for differences in metabolic rate per bodyweight, remaining differences are corrected with an AF of 2.5
- AF for intraspecies differences:
- 5
- Justification:
- Table R.8-6 ECHA REACH Guidance 'intraspecies': default factor for worker is 5.
- AF for the quality of the whole database:
- 1
- Justification:
- Table R.8-6 ECHA REACH Guidance 'quality of whole database': 1 is the default for a good quality database, taking into account completeness and consistency of the available data for the standard information requirements at the relevant tonnage band.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- acute toxicity
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.167 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
For systemic hazard assessment via the dermal route of exposure, route-to-route extrapolation from the oral NOAEL value was considered appropriate.
ECHA Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.8 section R8.4.2 states that when data on dermal penetration is available, dermal absorption is considered to be the same as oral absorption (i.e. 100 %). Therefore no default factor should be introduced when performing oral-to-dermal extrapolation & the oral NOAEL is considered to be the same as the dermal NOAEL.
- AF for dose response relationship:
- 1
- Justification:
- Table R.8-6 ECHA REACH Guidance 'dose-response': the dose-descriptor is a NOAEL therefore default value for systemic effects is 1.
- AF for differences in duration of exposure:
- 6
- Justification:
- Table R.8-6 ECHA REACH Guidance 'Exposure duration': default value for sub-acute to chronic is 6.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Table R8.3 ECHA REACH Guidance R8 'Allometric scaling factors for different species as compared to humans': Rat AS factor is 4.
- AF for other interspecies differences:
- 2.5
- Justification:
- Table R.8-6 ECHA REACH Guidance 'interspecies': after correction for differences in metabolic rate per bodyweight, remaining differences are corrected with an AF of 2.5
- AF for intraspecies differences:
- 5
- Justification:
- Table R.8-6 ECHA REACH Guidance 'intraspecies': default factor for worker is 5.
- AF for the quality of the whole database:
- 1
- Justification:
- Table R.8-6 ECHA REACH Guidance 'quality of whole database': 1 is the default for a good quality database, taking into account completeness and consistency of the available data for the standard information requirements at the relevant tonnage band.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Acute/short term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - workers
- parenteral NOAEL = 50mg/kg bw/day (linked to kidney effects classified as STOT RE2 (kidney)
- reproductive NOAEL = ≥650mg/kg bw/day
- developmental NOAEL = ≥650mg/kg bw/day
N-Phenyl-diethanolamine, reaction products with formaldehyde is not classified as a non-threshold mutagen/carcinogen, therefore relevant classifications & dose descriptors were considered from the available toxicity information as follows:
The substance is classified as a Sensitiser (category 1), a non-threshold effect. As such, for scenarios involving local dermal exposure, a qualitative hazard assessment was undertaken in line with ECHA Guidance on Information Requirements and Chemical Safety Assessment.
For Acute toxicity, no classifications were assigned, therefore there were no DNELs derived for short term/acute exposure periods.
For systemic long term scenarios, a combined repeated dose toxicity with reproductive/developmental toxicity screening study was available (OECD TG422). From this, the following NOAELs were available:
As no effects on reproduction and development were present, the most sensitive NOAEL for derivation of DNELs was considered to be the parenteral NOAEL linked to kidney toxicity.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.145 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 150
- Dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 21.7 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Absorption: ECHA Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.8 section R8.4.2 (2012) states that in the absence of reliable data for both the starting route (oral) and the end route (inhalation), worst-case assumptions should be made. It was therefore assumed that limited absorption occurs by the oral route, leading to a low (conservative) internal NOAEL. To secure a conservative external NOAEL, maximum absorption should be assumed for the inhalation route (i.e. 100%) leading to a low external NOAEL. Thus, in the case of oral-to-inhalation extrapolation, it is proposed to include a default factor of 2 (i.e. the absorption percentage by the oral route is half that of the inhalation absorption)
Physiological Parameters: To convert the oral NOAEL into an inhalatory NOAEC, the following physiological parameters were applied:
Symbol Parameter Value/Reference Systemic NOAELlong-term Oral systemic NOAEL from OECD422 in rats 50 mg/kg bw/day sRVrat standard Respiratory Volume - rat, 24h exposure period 1.15 m3/kg/day Calculation: The corrected dose descriptor for inhalation is determined using the following equation:
Corrected Inhalatory NOAEClong-term = Systemic NOAELlong-term x [(1/sRVrat) x (ABSoral-rat/ABSinh-rat) x (ABSinh-rat/ABSinh-human)].
Corrected Inhalatory NOAEClong-term = 50 mg/kg bw/day X [(1/1.15 m3/kg bw/day) X (1/2) X (2/2)].
Corrected Inhalatory NOAEClong-term = 50 mg/kg bw/day X 0.435
Corrected Inhalatory NOAEClong-term = 21.7 mg/m3
Therefore, the corrected dose descriptor for inhalation is 21.7 mg/m3 for the general population.
- AF for dose response relationship:
- 1
- Justification:
- Table R.8-6 ECHA REACH Guidance 'dose-response': the dose-descriptor is a NOAEL therefore default value for systemic effects is 1.
- AF for differences in duration of exposure:
- 6
- Justification:
- Table R.8-6 ECHA REACH Guidance 'Exposure duration': default value for sub-acute to chronic is 6.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Table R.8-4 ECHA REACH Guidance: An assessment factor or interspecies differences is not to be used for inhalation exposure since the differences in the metabolic rate/bw have already been taken into account in the corrected dose descriptor starting point.
- AF for other interspecies differences:
- 2.5
- Justification:
- Table R.8-6 ECHA REACH Guidance 'interspecies': after correction for differences in metabolic rate per bodyweight, remaining differences are corrected with an AF of 2.5
- AF for intraspecies differences:
- 10
- Justification:
- Table R.8-6 ECHA REACH Guidance 'intraspecies': default factor for general population is 10.
- AF for the quality of the whole database:
- 1
- Justification:
- Table R.8-6 ECHA REACH Guidance 'quality of whole database': 1 is the default for a good quality database, taking into account completeness and consistency of the available data for the standard information requirements at the relevant tonnage band.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.083 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
For systemic hazard assessment via the dermal route of exposure, route-to-route extrapolation from the oral NOAEL value was considered appropriate.
ECHA Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.8 section R8.4.2 states that when data on dermal penetration is available, dermal absorption is considered to be the same as oral absorption (i.e. 100 %). Therefore no default factor should be introduced when performing oral-to-dermal extrapolation & the oral NOAEL is considered to be the same as the dermal NOAEL.
- AF for dose response relationship:
- 1
- Justification:
- Table R.8-6 ECHA REACH Guidance 'dose-response': the dose-descriptor is a NOAEL therefore default value for systemic effects is 1.
- AF for differences in duration of exposure:
- 6
- Justification:
- Table R.8-6 ECHA REACH Guidance 'Exposure duration': default value for sub-acute to chronic is 6.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Table R8.3 ECHA REACH Guidance R8 'Allometric scaling factors for different species as compared to humans': Rat AS factor is 4.
- AF for other interspecies differences:
- 2.5
- Justification:
- Table R.8-6 ECHA REACH Guidance 'interspecies': after correction for differences in metabolic rate per bodyweight, remaining differences are corrected with an AF of 2.5
- AF for intraspecies differences:
- 10
- Justification:
- Table R.8-6 ECHA REACH Guidance 'intraspecies': default factor for general population is 10.
- AF for the quality of the whole database:
- 1
- Justification:
- Table R.8-6 ECHA REACH Guidance 'quality of whole database': 1 is the default for a good quality database, taking into account completeness and consistency of the available data for the standard information requirements at the relevant tonnage band.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Acute/short term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.083 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
No modification of the dose descriptor starting point was required. The endpoint used to derive the DNEL uses the oral exposure route.
- AF for dose response relationship:
- 1
- Justification:
- Table R.8-6 ECHA REACH Guidance 'dose-response': the dose-descriptor is a NOAEL therefore default value for systemic effects is 1.
- AF for differences in duration of exposure:
- 6
- Justification:
- Table R.8-6 ECHA REACH Guidance 'Exposure duration': default value for sub-acute to chronic is 6.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Table R8.3 ECHA REACH Guidance R8 'Allometric scaling factors for different species as compared to humans': Rat AS factor is 4.
- AF for other interspecies differences:
- 2.5
- Justification:
- Table R.8-6 ECHA REACH Guidance 'interspecies': after correction for differences in metabolic rate per bodyweight, remaining differences are corrected with an AF of 2.5
- AF for intraspecies differences:
- 10
- Justification:
- Table R.8-6 ECHA REACH Guidance 'intraspecies': default factor for general population is 10.
- AF for the quality of the whole database:
- 1
- Justification:
- Table R.8-6 ECHA REACH Guidance 'quality of whole database': 1 is the default for a good quality database, taking into account completeness and consistency of the available data for the standard information requirements at the relevant tonnage band.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - General Population
- parenteral NOAEL = 50mg/kg bw/day (linked to kidney effects classified as STOT RE2 (kidney)
- reproductive NOAEL = ≥650mg/kg bw/day
- developmental NOAEL = ≥650mg/kg bw/day
N-Phenyl-diethanolamine, reaction products with formaldehyde is not classified as a non-threshold mutagen/carcinogen, therefore relevant classifications & dose descriptors were considered from the available toxicity information as follows:
The substance is classified as a Sensitiser (category 1), a non-threshold effect. As such, for scenarios involving local dermal exposure, a qualitative hazard assessment was undertaken in line with ECHA Guidance on Information Requirements and Chemical Safety Assessment.
For Acute toxicity, no classifications were assigned, therefore there were no DNELs derived for short term/acute exposure periods.
For systemic long term scenarios, a combined repeated dose toxicity with reproductive/developmental toxicity screening study was available (OECD TG422). From this, the following NOAELs were available:
As no effects on reproduction and development were present, the most sensitive NOAEL for derivation of DNELs was considered to be the parenteral NOAEL linked to kidney toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.